Aoris Sells Sherwin-Williams: Structural Demand Worries Outweigh Share Gains

Aoris Investment Management sold its stake in Sherwin-Williams (SHW) during the first quarter and shifted the proceeds into Cintas (CTAS). The move, disclosed in the fund's Q1 2026 investor letter, signals that at least one institutional holder sees the paint maker facing headwinds that may not fade with the next rate cycle.

Aoris had owned SHW for years, drawn by its grip on the professional-painter market in the U.S. The letter explained why that thesis frayed. “A key driver of the paint market is the volume of property sales, as homes are often repainted after they’re purchased,” Aoris wrote. Higher mortgage rates and slower population growth have depressed home sales, pinching paint volumes. The industrial coatings business has also struggled with a sluggish industrial economy.

“Even though Sherwin-Williams has continued to grow its market share, we have become concerned that its end markets are structurally slower growing,” the letter stated. Aoris said it found a “higher quality business” in Cintas and made the swap.

Wall Street is split on the stock. Citi raised its price target to $380 from $355 on June 24 and kept a Buy rating. The bank had reinstated coverage on June 3 with a $355 target, calling the stock an attractive entry point on expectations of a cyclical recovery. That thesis assumes SHW's end markets are near a cyclical trough, not permanently impaired.

UBS took the opposite view. On June 2 it cut SHW to Neutral from Buy and slashed the target to $330 from $385, citing a more balanced risk-reward outlook.

Sherwin-Williams shares trade at 28.82 times forward earnings. The S&P 500 trades at roughly 21 times. That premium – roughly 37% above the index – assumes either above-average earnings growth or a re-rating that has not materialized. The stock is flat over the past twelve months and up 4.5% year to date.

AlphaScala's Alpha Score for SHW stands at 58 out of 100, a Moderate label. CTAS scores 35, a Mixed label. The swap from a moderately-rated stock to a mixed-rated one suggests Aoris is placing a heavier weight on business quality than on the quantitative reading.

The case for buying SHW rests on a cyclical recovery in home sales, which would lift paint volumes. That path requires mortgage rates to fall enough to revive transaction activity. The case against it rests on population trends – slower U.S. household formation – and industrial softness that may persist after rates ease. Right now the analyst divergence gives traders no clear consensus, only two competing bets.